Clinical Research Directory
Browse clinical research sites, groups, and studies.
Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic Approach
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Summary
Multicentric prospective study with collection of biological samples as part of type II research
Official title: Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
1100
Start Date
2018-01-22
Completion Date
2024-12
Last Updated
2024-06-12
Healthy Volunteers
No
Conditions
Interventions
Stool
collection at baseline (or before the third injection), at the first evaluation (CT-scan), at ≥ 6 months after the first injection, at toxicity and at relapse, at 1 week after the end of antibiotics treatment
Blood sample
20 mL collection at baseline (or before the third injection), at the first evaluation (CT-scan), at ≥ 6 months after the first injection, at toxicity and at relapse, at 1 week after the end of antibiotics treatment
Locations (9)
Gustave Roussy
Villejuif, Val De Marne, France
Centre hospitalier du Pays d'Aix
Aix-en-Provence, France
Centre Pierre Curie
Beuvry, France
Clinique du Flandre
Coudekerque-Branche, France
CHRU Lille - Hôpital Calmette
Lille, France
Centre Léon Bérard
Lyon, France
Hôpital St Louis
Paris, France
Hôpital Foch
Suresnes, France
Centre hospitalier TOULON - Sainte-Musse
Toulon, France